The Hackett Group (HCKT) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
17 Feb, 2026Executive summary
Q4 2025 revenues before reimbursements reached $74.8 million, exceeding guidance but down from $77.5 million year-over-year, with adjusted EPS at $0.40, the high end of the range but below $0.47 in Q4 2024.
Aggressive pivot to GenAI-enabled platforms, including AI Explorer, XT, AI X, and Ask Hackett, is driving new revenue streams and higher margins.
GAAP diluted EPS rose to $0.21 from $0.12 year-over-year, impacted by non-cash compensation and acquisition-related expenses.
Completed a Dutch auction tender offer, repurchasing 2.0–2.1 million shares for $41.2–$42 million, reducing outstanding shares by 7%.
Cash flow from operations was $19.1 million, supporting dividends and buybacks.
Financial highlights
Adjusted EBITDA was $15.9 million (21.3% margin), down from $19.5 million (25.2%) year-over-year.
Total Q4 2025 revenue was $75.8 million (vs. $79.2 million in Q4 2024).
Adjusted net income was $10.9 million; GAAP net income was $5.6 million.
Cash balance at quarter-end was $18.2 million, up from $13.9 million in the prior quarter.
Top 10 customers accounted for 23% of total revenue.
Outlook and guidance
Q1 2026 revenues before reimbursements expected between $70.5M–$72M; SAP segment to grow year-over-year, S&BT and Oracle segments to be down year-over-year but up sequentially.
Adjusted EPS guidance for Q1 2026 is $0.34–$0.36; adjusted gross margin expected at 44%–45%.
AI transition charges of $1M–$1.5M expected in Q1 2026 due to headcount reductions.
First quarterly dividend of $0.12 per share declared, payable April 3, 2026.
Latest events from The Hackett Group
- Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q2 revenue and EPS exceeded guidance, with Gen AI investments and strong cash flow.HCKT
Q2 20242 Feb 2026 - Q3 revenue and adjusted EPS beat guidance; GenAI growth accelerated by LeewayHertz acquisition.HCKT
Q3 202417 Jan 2026 - Q4 results beat guidance on SAP and GenAI strength; GenAI investments to drive 2025 growth.HCKT
Q4 202423 Dec 2025 - Shareholders will vote on director elections, stock plan expansion, executive pay, and auditor ratification.HCKT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - Q2 revenue up 1.6% to $78.9M; Gen AI drives growth, but costs weigh on net income.HCKT
Q2 202523 Nov 2025 - GenAI-fueled growth drove strong Q1 results, despite lower net income from higher expenses.HCKT
Q1 202521 Nov 2025